HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

delta-Aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia. Hypercatabolism caused by the increased susceptibility to the controlling protease.

Abstract
Properties of delta-aminolevulinic acid synthetase in erythroblasts of patients with pyridoxine-responsive anemia were investigated with special reference to the protease in mitochondria of erythroblasts. delta-Aminolevulinic acid synthetase activity in erythroblasts of patients with this disease before treatment was extremely decreased, whereas it gradually increased in parallel with the improvement of anemia by the therapy with pyridoxal phosphate. The amount of apo-delta-aminolevulinic acid synthetase in erythroblasts before treatment was also extremely diminished. Apparent affinity to pyridoxal phosphate of the apo-delta-aminolevulinic acid synthetase obtained from erythroblasts of the patients was almost the same as that of normal controls. The activity of a new protease which is considered to be engaged in the regulation of delta-aminolevulinic acid synthetase levels in mitochondria of erythroblasts was shown to be in normal range in erythroblasts of the patients. On the other hand, apo-delta-aminolevulinic acid synthetase obtained from the patients was extremely sensitive to the protease. These results indicate that disturbance of heme synthesis characteristic to pyridoxine-responsive anemia could be ascribed to the hypercatabolism of delta-aminolevulinic acid synthetase caused by the increased susceptibility to the controlling protease in erythroblasts.
AuthorsY Aoki, S Muranaka, K Nakabayashi, Y Ueda
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 64 Issue 5 Pg. 1196-203 (Nov 1979) ISSN: 0021-9738 [Print] United States
PMID500806 (Publication Type: Journal Article)
Chemical References
  • Enzyme Inhibitors
  • Pyridoxal Phosphate
  • 5-Aminolevulinate Synthetase
  • Endopeptidases
Topics
  • 5-Aminolevulinate Synthetase (metabolism)
  • Anemia, Hypochromic (drug therapy, enzymology)
  • Anemia, Sideroblastic (drug therapy, enzymology)
  • Bone Marrow (enzymology, ultrastructure)
  • Bone Marrow Cells
  • Endopeptidases (metabolism)
  • Enzyme Inhibitors (metabolism)
  • Humans
  • Mitochondria (enzymology)
  • Pyridoxal Phosphate (therapeutic use)
  • Vitamin B 6 Deficiency (drug therapy, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: